Inflammatory Risk in Statin-Treated Patients
December 11, 2024 | Pooling data from the PROMINENT, REDUCE-IT, and STRENGTH trials, Paul Ridker and C. Michael Gibson discuss the residual inflammatory risks for patients treated with statins. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.